CORCEPT THERAPEUTICS I
54.30
07-November-24 14:59:58
15 minutes delayed
Stocks
+0.07
+0.13%
Today's range
53.65 - 55.24
ISIN
N/A
Source
NASDAQ
-
William Guyer to join Corcept as Chief Development Officer
12 Aug 2021 16:00:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
29 Jul 2021 15:05:03 By Nasdaq GlobeNewswire
-
12 Jul 2021 07:30:00 By Nasdaq GlobeNewswire
-
22 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
15 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
10 Jun 2021 06:30:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
06 May 2021 15:10:00 By Nasdaq GlobeNewswire
-
06 May 2021 15:01:01 By Nasdaq GlobeNewswire
-
29 Apr 2021 15:05:01 By Nasdaq GlobeNewswire
-
15 Mar 2021 06:30:00 By Nasdaq GlobeNewswire
-
01 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results
23 Feb 2021 15:05:00 By Nasdaq GlobeNewswire
-
08 Feb 2021 15:05:00 By Nasdaq GlobeNewswire
-
01 Feb 2021 15:05:00 By Nasdaq GlobeNewswire